Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407706
Status:
UNKNOWN
Last Update Posted:
2006-12-05
First Post:
2006-12-04
Brief Title:
Using Test of SCM for Detection Breast Cancer
Sponsor:
Ziv Hospital
Organization:
Ziv Hospital
Study Overview
Official Title:
Breast Cancer- Early Detection of Cancer Disease and Pre-Cancer Disease and in Women That Are at High Risk for Developing Breast Cancer by Identifying Lymphocytes Previously Exposed to Specific Cancer Antigen
Status:
UNKNOWN
Status Verified Date:
2006-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In our previous research we have shown that women that have breast cancer have a population of lymphocytes that recognizes specific antigen and there cytoplasmic matrix goes through physical change a short time after exposure in vitro to the same antigen This change can be measured by polarization changes of fluorescent light emitted by FDA fluorescein diacetate labeled cells Further test that we performed showed that those differences are also shown in a benign situation that known as indicator for a high risk for developing breast cancer within 10-15 years The incidence of the expression of these lymphocytes correlates with the histopathological picture as it is related in high risk for the developing the disease
In this work we will expand the scope of the procedure to early detection of the cancerous process in breast lesions by Fitzgibbons risk categories for the development invasive carcinoma of the breast In the proposed work we intend to use specific antigen MUC1 for breast cancer This study is a continuation of our published work in the The Breast
In this work we will expand the scope of the procedure to early detection of the cancerous process in breast lesions by Fitzgibbons risk categories for the development invasive carcinoma of the breast In the proposed work we intend to use specific antigen MUC1 for breast cancer This study is a continuation of our published work in the The Breast
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None